Broken drug markets in infectious diseases: Opportunities outside the private sector?

A subset of anti-infective drugs are increasingly unavailable for patients in the United States due to pricing or withdrawal from the market. Timely market solutions are needed. We assert that solutions to ensure access to some essential anti-infective agents lie outside capital markets and that pub...

Full description

Bibliographic Details
Published in:PLOS Neglected Tropical Diseases
Main Authors: Jonathan D Alpern, Stephen J Dunlop, William M Stauffer
Format: Article in Journal/Newspaper
Language:English
Published: Public Library of Science (PLoS) 2019
Subjects:
Online Access:https://doi.org/10.1371/journal.pntd.0007190
https://doaj.org/article/8376d994e1f04990847a43024a4682c7
Description
Summary:A subset of anti-infective drugs are increasingly unavailable for patients in the United States due to pricing or withdrawal from the market. Timely market solutions are needed. We assert that solutions to ensure access to some essential anti-infective agents lie outside capital markets and that public-private partnerships may be the most viable solution.